Objective To further elucidate the origin of the physiological CA-125 amounts that lead to
cyclic changes in CA-125 serum levels in normally menstruating women. Design Fifty-three …

Objective To measure uterine fluid CA-125 concentration and to determine if any menstrual
cycle phase dependent changes exist in its level. Serum levels are measured for …

Background Serum CA-125 has been used as a biomarker of gynecological tumors. In this
study, we investigated the CA-125 levels in cervical and vaginal secretions from Chinese …

CA-125 is an antigenic determinant expressed on ovarian cancer cells and serves as serum
marker in patients with ovarian cancer. It has also been detected, however, in serum of …

CA-125 is a high-molecular-weight glycoprotein that is expressed on the cell surface of
some derivatives of embryonic coelomic epithelium. Based on results of an …

CA-125 is a 220-kD cell surface glycoprotein present in over 80% of non-mucinous
epithelial ovarian carcinomas and it occurs in the serum of healthy males and females at low …

The origin of physiological CA-125 serum levels, which in normally menstruating women
were shown to depend on their actual menstrual cycle phase, has not yet been completely …

Objective To determine CA-125 concentrations and total amounts in peritoneal fluid (PF) of
women with various infertility-related factors throughout the menstrual cycle. Design …

Materials and methods Endometrial tissue was obtained from women in proliferative (n= 5),
early secretory (ES; n= 4) and late secretory (LS; n= 4) phase as well as glandular-cystic …

Objective. Cancer antigen-125 (CA-125) is not a specific tumor marker and it is synthesized
by normal and malignant cells of different origins. Recently it has been shown that various …